Mega Doctor News
- Advertisement -
The development of glucagon-like peptide-1 (GLP-1) drugs, such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss, researchers and medical professionals have raised concerns about the accompanying loss of muscle tissue. This Special Feature discusses the challenges associated with assessing changes in muscle mass that accompany GLP-1 drug-induced weight loss, the potential impact of muscle mass loss, and how to preserve muscle mass.
Follow the link below to Medical News Today to read the full story:
- Advertisement -
Information: https://www.medicalnewstoday.com
- Advertisement -
